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Abstract
Background: In England, since 2015, there has been a formal drive to integrate pharmacists into general practice
as a new healthcare service. Research efforts have offered insights into how general practice-based professionals
and patients view the service, however, they took no account of community pharmacy teams’ opinions. There have
been anecdotal statements about opposition from community pharmacies to the service, due to fears of losing
business. The aim of the current study was to identify the experiences and perceptions of community pharmacy
teams regarding pharmacists’ presence in general practice.
Methods: The National Health Service Choices website was used to identify community pharmacies within a radius
of two miles from eight West London general practices. The search resulted in 104 community pharmacies which
were all contacted via telephone. Pharmacy staff who verbally expressed their interest to participate were then
provided with the study’s documents. Qualitative, face-to-face, semi-structured interviews were conducted inside
the pharmacy from which each participant was recruited. Interviews lasted 30 to 45 min and were audio-recorded.
Audio-recordings were transcribed verbatim and transcripts analysed thematically.
Results: Forty-eight community pharmacy staff participated. Four themes were discerned: awareness (“I knew that
[pharmacists] have already been implemented [in general practice] but I haven’t really followed it … where does
the pharmacist role come?”); interactions (“I’m just so pleased that there’s a pharmacist professional in the general
practice … because we speak the same language!”); patient care (“if I was a patient knowing that there is a general
practitioner and a pharmacist [in general practice], I would … think ‘nothing can go wrong at the moment’”); and
funding challenges (“if general practices take on the extra responsibility of stop smoking or flu vaccination
campaigns … financially, this would affect this pharmacy”).
Conclusions: The current study revealed the perceived impact of general practice-based pharmacists on
community pharmacies would be improved communication between pharmacies and practices. Findings will
inform policy so that any future framing of pharmacists’ presence in general practice considers the needs of
community pharmacies.
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Background
England is experiencing pressures in the delivery of pri-
mary healthcare due to an ageing population with mul-
tiple co-morbidities and significant difficulties in
recruiting and retaining general practitioners (GPs) [1,
2]. To address these pressures and make effective use of
the workforce (including a projected excess of recently
qualified pharmacists by 2040 [3]), a national, two-
phased scheme for integrating pharmacists into general
practice was launched in 2015 by the National Health
Service (NHS) England [4, 5]. The scheme introduced
over 1000 pharmacists into general practice [6]. In early
2019, the NHS Long Term Plan [7] encouraged general
practices to work together in Primary Care Networks
(PCNs). PCNs are organisations covering 30–60,000 pa-
tients with the remit to connect community-based
healthcare services with each other as well as with the
hospital, social and voluntary sectors. As part of a new
contract between general practices and NHS England,
PCNs will be funded £1.8 billion to hire an additional
20,000 primary care staff within the next 5 years includ-
ing large numbers of general practice-based pharmacists
[8]. General practice-based pharmacists in England carry
out a wide spectrum of activities, the majority of which
focus on providing expertise around medication use [9–
12]. Characteristic examples of activities are face-to-face
patient clinics for managing long-term conditions and/
or acute care and/or medication reviews, including ele-
ments of physical assessments; drug monitoring includ-
ing dealing with high-risk drugs and ordering laboratory
or other clinical tests; lifestyle advice, for example,
weight management, diet and smoking cessation; tele-
phone consultations with patients for triage and com-
mon ailments such as management of pain; medicines
reconciliations; prescribing, if qualified to do so; man-
aging the repeat prescription service; and advising gen-
eral practice-based staff on medication-related queries.
Internationally, several countries have formally
attempted to integrate pharmacists into general practice.
For example, several programmes have been introduced
in different parts of Australia, all of which have been
small-scale [13–16]. In Canada, large-scale programmes
of implementing pharmacists’ services into general prac-
tice have taken place in Ontario and Quebec [17, 18]
whereas smaller efforts have been also made in
Newfoundland and Labrador [19]. In the USA, efforts of
introducing general practice-based pharmacists have in-
volved a small number of pharmacists/practices and
have been restricted to a very certain geographical loca-
tion [20–24]. However, there are a few instances of
wider programmes such as the ‘Collaboration Among
Pharmacists and Physicians to Improve Outcomes Now’
which ran across 13 states [25]. In New Zealand, govern-
mental programmes implemented 31 general practice-
based pharmacists nationwide by 2017 [26]. In
Netherlands, a relatively recent initiative introduced ten
general practice-based pharmacists [27].
Although some pharmacists in England have occasion-
ally worked in general practice in the past [28, 29], this
is the first time that the role has been formally imple-
mented and tested at a national level [30]. As a result,
very little is known about the impact of pharmacists in
general practice. A preliminary evaluation of the first
phase of the English scheme reported benefits for GPs
(including increased capacity and a more focused work-
load), patients (including longer appointments with the
same person) and pharmacists (including increased role
satisfaction) [31]. The evaluation, however, did not ac-
count for the perceptions of community pharmacy staff.
Staff in community pharmacies mainly consists of phar-
macists, including pre-registration pharmacists, and
pharmacy technicians.
Community pharmacies are independent contractors
of NHS England and are integral to the care of patients.
There are currently about 11,600 community pharmacies
across England [32]. Many of these pharmacies operate
long hours, hence providing patient care at times when
other healthcare services are unavailable and/or serve
small, deprived communities where access to healthcare
is hard.
As part of their contract, community pharmacies pro-
vide three tiers of services, namely ‘essential’, ‘advanced’
and ‘locally commissioned’ [33–35]. All these services
are carried out by pharmacists. The ‘essential’ services
are required from all community pharmacies whereas
the ‘advanced’ and ‘locally commissioned’ services are
provided on an optional basis. The ‘essential’ services in-
clude dispensing duties, liaising with other healthcare
settings when needed (in particular general practices),
disposal of medical waste and referral of patients to the
appropriate healthcare professional. ‘Advanced’ services
refer to tasks such as the adherence-focused medicine
use reviews (MURs), to be phased out by the end of
2020; the new medicine service (NMS); flu vaccinations;
and providing emergency medication supplies to pa-
tients. Community pharmacies receive payment for of-
fering ‘advanced’ services and as such employers expect
pharmacists to meet certain targets for their provision.
‘Locally commissioned’ services include minor ailment,
smoking cessation, lifestyle advice and vascular risk as-
sessment services. Pharmacy technicians, under the
supervision of a pharmacist, provide various services in
community pharmacies, for example, processing pre-
scriptions, preparing and dispensing medications, order-
ing items and managing stocks, liaising with staff in
other healthcare settings and advising patients on their
medications as well as on minor ailments and smoking
cessation [36, 37].
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There are existing interactions between community
pharmacies and general practices, mainly around pre-
scriptions [38, 39]. However, the increase in number of
pharmacists in general practice and the roles they can
undertake (for example, medication reviews) has anec-
dotally caused some opposition and resistance from
community pharmacy teams to the integration of phar-
macists into general practice. These rumours are based
on fears of losing business due to role clashes, for ex-
ample, general practice-based pharmacists’ medication
reviews replacing MURs and the NMS [40, 41]. A few,
mostly international studies examining collaboration be-
tween community pharmacies and general practice fo-
cused on the views of general practice-based
pharmacists and other staff, rather than on the opinions
of community pharmacy teams [42–46]. Therefore, there
is a gap in the literature examining the impact of general
practice-based pharmacists on community pharmacies.
The aim of the current study was to explore commu-
nity pharmacy teams’ experiences and perceptions of the
presence of pharmacists in general practice in England.
Methods
Study design
To pursue an in-depth exploration of experiences, a
qualitative study design was selected. Individual inter-
views, rather than focus groups, were selected as partici-
pants might not have felt comfortable to discuss their
honest views in front of other co-participants, especially
if there were areas of disappointment/frustration. All in-
terviews were conducted between October and Decem-
ber 2017.
Setting
Participants were recruited from community pharmacies
within the geographical area of one West London GP
Federation (a cohort of practices working together as a
collective entity) which constituted a ‘pharmacists in
general practice’ site. At the time of data collection, eight
Federation practices participated in the scheme, employ-
ing seven pharmacists and serving approximately 72,000
patients. This Federation was targeted as a recruitment
point due to working connections with the research
team’s organisation.
Participants and recruitment
Potential participants included community pharmacists
(either regular or locum), pre-registration pharmacists
and pharmacy technicians. Pharmacy technicians were
included because they are an important part of commu-
nity pharmacy teams with expanding roles and responsi-
bilities that support pharmacists in their roles [47, 48].
The NHS Choices website was searched to identify all
community pharmacies within a two-mile radius of the
postcodes of the eight practices. This identified 104
pharmacies (61 independent, 24 small chain, 13 large
chain and six supermarket pharmacies). Names, ad-
dresses and phone numbers for the pharmacies were re-
trieved. Ten interviewers (final year pharmacy students
trained to undertake interviews) were paired and each
pair was randomly assigned 20 or 21 pharmacies. Each
pharmacy was contacted by telephone and the respon-
sible pharmacist introduced to the study and asked if
they, or a member of their staff, were willing to partici-
pate. People who expressed their willingness to partici-
pate were provided, by e-mail or post, with information
about the study including details on the research team
and interviewers. After a week, invitees were again con-
tacted by telephone to schedule an interview.
Data collection
Participation in the interviews was voluntary. Regular
debriefings between the research team (GDK, KR, NP
and GS) and the interviewers were held throughout the
data collection period. GDK is a doctoral research stu-
dent, KR is a Professor of Social Pharmacy, NP is an As-
sociate Professor in Pharmacy and GS is a lead general
practice-based pharmacist. All interviews were face-to-
face, semi-structured, audio-recorded and conducted
within the pharmacies in a quiet place of mutual con-
venience. An interview schedule, composed of open-
ended questions and prompts, was used (see Table 1).
Each interview terminated when the participant did not
Table 1 Interview schedule
Thank you for taking the time to contribute to our research project.
1. What are your roles and responsibilities within this pharmacy?
• Your role, age, years of service
• Skills and training
• Day-to-day working life
2. Please tell us about your perceptions of pharmacists working in
general practice.
• Positives/negatives
• Perceived impact on your own roles, responsibilities
• Actual experiences or hearsay (where from?)
3. Please tell us about your experiences, if any, of the pharmacists in
general practice scheme
• Relationships – with GPs, pharmacy team members
• Positive/negatives - examples
• Impact on own roles, responsibilities
4. Overall view of the GP-pharmacist partnership on your work/ser-
vices provided
• Feelings
• Thoughts about how your work has changed
• What changes would you like to see made to the scheme?
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have anything else to share. Interviews lasted 30 to 45
min.
Data analysis
Audio-recordings were transcribed verbatim by the in-
terviewers. Transcripts were inductively coded [49] using
NVivo 11 and analysed thematically by GDK as de-
scribed by Braun and Clark (familiarisation with data;
coding; searching for themes; reviewing themes; defining
and naming themes; and developing the report) [50].
Coding was verified by the rest of the research team be-
fore developing categories. Categories were re-assessed
and collapsed into potential themes with associated sub-
themes. Themes were then refined and named collect-
ively by the research team. Participants’ feedback on
transcripts or findings was not sought.
Results
Demographics
Table 2 provides an overview of the participants’ demo-
graphics. Forty-eight community pharmacy staff partici-
pated in the study. Of these, most were pharmacists with
a wide range of time spent in community pharmacy. The
majority of participants worked for independent
pharmacies.
Themes
Four overarching themes were discerned in the data:
awareness; interactions; patient care; and funding chal-
lenges. Figure 1 illustrates the four themes with all asso-
ciated sub-themes.
Awareness
Participants’ awareness of pharmacists in general prac-
tice varied. Some were completely ignorant of their pres-
ence or thought that a general practice-based
pharmacist meant a pharmacy situated within the
practice.
To be honest, I don’t know anything about the scheme
[of integrating pharmacists into general practice] so
I’m not able to speak about it. (Pharmacist 25)
The majority of participants, though, were aware of
pharmacists’ presence in general practice but uncertain
about details such as employment models, roles and
responsibilities.
I knew that [pharmacists] have already been imple-
mented [in general practice] but I haven’t really followed
it … where does the pharmacist role come? For example,
I don’t know if they see the patient [together] with the
GP or if they have their own room or like clinic or what-
ever where they can see patients. (Pharmacist 28)
Participants attributed their limited awareness of the
topic to a lack of formal publicity about the scheme.
They reported, for example, that general practices had
not informed community pharmacies about the integra-
tion of a pharmacist or the specific roles this pharmacist
would undertake.
General practices never told community pharmacy
teams that there’s going to be a pharmacist inte-
grated into them. It’s just when we see a prescription
that has a name and pharmacist prescriber [that we
understand there is a pharmacist in a practice]. And
then, there was one incident where the pharmacist
[in general practice] actually phoned [us] for some
information and that was the first time we knew
that the practice had a pharmacist. (Pharmacist 10)
Participants also reported receiving no information on
the scheme from NHS England or pharmacy profes-
sional bodies, including upcoming rounds of recruit-
ment, number of posts, job security matters or the
longevity of the role. They said they were opportunistic-
ally updated on the topic via self-research, such as read-
ing online documents including job applications, or
through friends or family working in general practice.
There is not a lot of information about pharmacists
in general practice out there. No General Pharma-
ceutical Council (GPhC) [the responsible body for
regulating the pharmacy profession in England,
Scotland and Wales] e-mails, nothing whatsoever. I
think that if GPhC wants this [pharmacists’ integra-
tion into general practice] to go through, they have
to advertise it more. We have so little update from
them! (Pharmacy technician 8)
Participants highlighted the importance of being made
aware of the presence of a pharmacist in a general prac-
tice so that they had some time to adjust and avoid
awkwardness.
Table 2 Demographics of participants
Total number interviewed Years of experience in community pharmacy
Pharmacists 32 4 months to 44 years
Pre-registration pharmacists 8 2 to 5 months
Pharmacy technicians 8 1 to 30 years
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It’s like ‘are we being told off’? But ultimately you’d
just have to think that if it’s to do with patient care
and streamlining everything and making things
quicker, as long as we’re told that there’s a pharma-
cist now employed [in a general practice] to do this
and this. (Pharmacist 2)
Community pharmacy teams had specific informa-
tion needs including the time scales for recruiting
general practice-based pharmacists; the practices in-
volved; the precise targets that a practice aims to
achieve with the integration of a pharmacist; the ben-
efits for the surrounding community pharmacies; and
the times during which pharmacists are available in a
practice, especially for pharmacists covering multiple
practices.
Interactions
There were a few participants without any sort of
interaction with a general practice-based pharmacist.
I know that some of our prescriptions come from
a pharmacist prescriber in general practice. But I
have never personally spoken to that person.
(Pharmacist 31)
Queries and/or problems on prescriptions issued by
general practices were the main reasons for interactions,
usually over the telephone, between community phar-
macy teams and general practice-based pharmacists.
These queries included missing items on a repeat pre-
scription, need for dose amendments and need for an al-
ternative prescription if a product was out of stock.
[Community pharmacies] do dosette boxes [for stor-
ing scheduled doses for a patient’s medications to
aid adherence]. When there has to be changes in the
dosette boxes, we speak to the general practice-based
pharmacist. So, that’s the main interaction we have:
any prescription they [general practice-based phar-
macists] issue, if there’s a query in that prescription
Fig. 1 Themes and subthemes of community pharmacy teams’ experiences of pharmacists in general practice
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like a dose amendment then we speak to them.
(Pharmacist 1)
Participants emphasised their satisfaction about being
able to speak to another pharmacist on the telephone
when engaging with general practices. Community phar-
macists, including pre-registration pharmacists, felt more
comfortable and at ease speaking to another pharmacist
than speaking to a GP. They attributed this feeling to
intra-professional bonds that make interactions with
somebody at the same level and with similar training
easier.
When I call [doctors] there is a bit of clash and I just
feel if I speak to a pharmacist [in general practice]
it’s so much easier. There is always that awkward-
ness between doctors and pharmacist. For example, I
was once on the phone with a doctor and he said ‘I
have no time for this’. I would not say that to some-
body. (Pharmacist 21)
Fellow pharmacists were thought to fully understand
the business side of community pharmacy and its impli-
cations, as opposed to receptionists or GPs who have
historically dealt with queries from community phar-
macy teams.
It’s great that I can pick up the phone and speak to
a pharmacy member of [general practice] staff who
understands what I mean by dosette or why I need a
prescription. For example, you have ordered ten
items for a repeat and [general practice] issue nine.
Receptionists will say ‘I will do it tomorrow or the
day after, it’s not urgent’. They don’t realize it’s
popped in the dosette and it needs to go at the same
time. Receptionists sometimes don’t get these basic
things because to them that’s foreign stuff. But in the
world of pharmacy that’s just minor. (Pharmacist
20)
I’m just so pleased that there’s a pharmacist profes-
sional in the general practice. I’m so happy about it
because we speak the same language! GPs are so re-
motely unaware of many things [in community
pharmacy]. (Pharmacist 3)
Participants also highlighted that it is easier to contact
a pharmacist in general practice than a GP. Quick access
resulted in resolution of queries and timely issue of pre-
scriptions. The presence, therefore, of pharmacists in
general practice was believed to reduce workload stress
on community pharmacy teams by streamlining the dis-
pensing process and avoiding multiple phone calls to
practices.
I feel the pharmacist [in general practice] is more ac-
cessible than a doctor, because obviously doctors are
very busy. For example, if I want to query a patient’s
dose [on a prescription issued by the practice] it’s
very easy to get through to a pharmacist. Because by
the time we contact and get to a doctor and the re-
ceptionist is like ‘The doctor is busy, I don’t know
when they can call you, it can be today, it can be to-
morrow’. But with the pharmacist it is ‘Okay, let’s do
this right now’. I get a quick reply, so it’s very good.
(Pharmacy technician 3)
Conversely, a few participants reported occasional dif-
ficulties in accessing the pharmacist in general practice,
citing the absence of a direct line and variable availabil-
ity. Moreover, said one participant, high workload pres-
sures led general practice-based pharmacists to refuse to
deal with more than one query at a time.
Participants thought pharmacists’ presence in general
practice has resulted in enhanced communication and
better relationships between community pharmacies and
general practices. For instance, practices with an inte-
grated pharmacist were thought to more readily consider
reports from community pharmacies, for example, inves-
tigating identified cases of hypnotics’ overuse. In
addition, they thought that GPs, who employed a
pharmacist, were more likely to ask community pharma-
cists for guidance on prescribing.
There can be a real communication gap between
surgeries and [community] pharmacies. This gap
closes down having [a pharmacist] be part [of] that
setting. And then the general practices that have a
clinical pharmacist on site, they’re always very wel-
coming and always more willing to help and com-
municate with a pharmacist that’s calling out from
the community because they appreciate [the phar-
macist’s] role. (Pharmacist 5)
One participant, however, mentioned that practices
covered by the same pharmacist refused to handle pre-
scription requests at times when pharmacists were not
physically present in the practice. Participants also noted
that there is still room for improved communication be-
tween community pharmacies and general practices. For
instance, participants emphasised the importance of es-
tablishing face-to-face interactions and familiarity with
general practice staff as a springboard for closer working
relationships and mutual support.
I think the working relationships will improve a lot
more if community pharmacy teams could actually
face-to-face meet these people [general practice-
based staff], with whom we speak on the phone. For
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example, they could tell us what their problems are
and we can see if we can make any changes to make
their lives easier. And we can tell them what our
problems are and they can help sort them out. At
the end of the day you have one neutral person, the
patient. (Pharmacist 19)
Patient care
Participants thought that the integration of pharma-
cists into general practice has led to improved satis-
faction and better quality of care for patients. For
example, faster processing of prescriptions meant
shorter waiting times and enhanced safety, especially
patients’ ability to receive antibiotics and emergency
medicines quickly.
Participants were confident that general practice-based
pharmacists clinically screen all prescriptions before they
are signed and forwarded to community pharmacies.
They were not confident that screening happened when
receptionists and GPs processed prescriptions. Careful
screening was believed to identify prescription problems,
such as incorrect doses, obsolete items and unsynchro-
nised repeat medication. Screening could also identify
unsatisfactory adherence, potential interactions and ad-
verse effects that otherwise might have been missed.
General practice-based pharmacists pick up more
than what the GP would, for example … if we re-
quest a prescription [from the practice], the recep-
tionist puts the prescriptions down and then the
doctor just rush-signs them whereas a pharmacist on
site takes more time looking at things and realising
that patients are actually overusing or underusing
[medicines]. (Pharmacy technician 2)
GPs’ skills in diagnostics combined with pharmacists’
expertise in medications was perceived to be an ideal ap-
proach to patient care.
If I was a patient knowing that there is a GP and a
pharmacist [in general practice], I would kind of
automatically think ‘Nothing can go wrong at the
moment, two professions combining together that
must be the correct thing for me’. (Pre-registration
pharmacist 6)
Funding challenges
There were concerns that pharmacists’ integration into
general practice was associated with cuts in the funding
of community pharmacies. Participants thought, without
corroborating evidence, that there had been a diversion
of central funds from community pharmacies to general
practices to support the new role.
I know that there definitely have been cuts be-
cause I know some pharmacies have been closed
down. So that is definitely true, but, where policy-
makers have actually put the money obviously no
one knows. But because this is a new role, it
makes sense that they’re just kind of pushing
funding all in there. (Pharmacist 12)
There were also fears that certain services traditionally
carried out in community pharmacies could potentially
be provided by general practice-based pharmacists,
thereby negatively affecting the profitability of commu-
nity pharmacies. Examples included MURs and other
patient-facing services.
If, for example, general practices take on the extra
responsibility of stop smoking or flu vaccination
campaigns, then it is possible that some of the pa-
tients who would have normally come to my phar-
macy will go to the practice for it. General practices
have the capacity now to do these additional services
because of an extra pharmacist. Financially, this
would affect this pharmacy. If a general practice has
done a smoking cessation service, they would get the
registration fee, they would get the quit [compensa-
tion] and yet I would be providing the medication.
So, all I get would be the cost of medication and
nothing else. (Pharmacist 26)
Finally, the widespread use of generic medications be-
cause of the presence of general practice-based pharma-
cists meant reduced income for community pharmacies
due to lower reimbursements.
I have personally seen a drop in our remuneration
and it pinches you. This is because general practice-
based pharmacists try and put more generics every-
where, if they can, because a lot of the drugs initially
were all branded and now it’s basically as many ge-
nerics. So, it’s less income [for us] because obviously
the brands are a lot more expensive and increase
our turnover overall. (Pharmacist 24)
To counterbalance funding reductions, participants
claimed that they would have to increase over-the-
counter medication sales, and pursue additional qualifi-
cations (for example, clinical diplomas) to increase the
range of services they could offer.
Discussion
Findings indicate a lack of awareness amongst commu-
nity pharmacy teams of various aspects of general
practice-based pharmacy services. Conversely, improved
communication has resulted in more timely and safer
Karampatakis et al. BMC Health Services Research          (2020) 20:431 Page 7 of 11
patient care. The financial viability of community phar-
macy, however, is still a concern. Despite these few con-
cerns, the majority of participating community
pharmacy staff did not oppose to the scheme and were
supportive of pharmacists’ integration into general
practice.
The findings can be interpreted using the ‘structur-
ation model of collaboration’ developed by D’Amour
and colleagues [51]. This theoretical framework analyses
intra- and inter-professional collaboration in healthcare.
It consists of four dimensions, two of which (internalisa-
tion; shared goals and vision) examine relationships be-
tween professionals and two (governance; formalisation)
that examine organisational aspects influencing
collaboration.
If we take the dimensions that examine relation-
ships between professionals, in the current study
these would refer to the relationships between com-
munity pharmacy teams (participants) and general
practice-based pharmacists. These two cohorts of
people will be our collaborating parts of interest,
which in the ‘structuration model of collaboration’ are
described as the ‘actors’ in collaboration. To begin
with internalisation (composed of trust and acquaint-
anceship), in our study, was obtained by intra-
professional bonds between ‘actors’ and confidence
that general practice-based pharmacists functioned as
a safety net on prescriptions. Participants’ sense of
‘having one of them in general practice’ was the
element that bridged gaps between organisations
(practices and pharmacies). Barriers to internalisation
were participants’ insufficient knowledge of roles and
absence of face-to-face acquaintanceship between ‘ac-
tors’. Participants conceptualised the dimension of
shared goals and vision by quoting the benefit of the
patient as the reason for both ‘actors’ to tighten rela-
tionships. It is unclear, however, whether or not ‘ac-
tors’ had the chance to explicitly communicate this
goal since most mutual interactions were brief, non-
face-to-face discussions on prescription matters. Po-
tential failure of both ‘actors’ to focus on the interests
of the patient could activate allegiances to personal
interests (such as participants’ keenness to defend
their existing funding status) that could preclude mu-
tual understanding.
Regarding organisational dimensions, formalisation
(entailing how the clinical care is structured) was indi-
cated in the way general practice-based pharmacists
were easily accessible, often via direct telephone lines,
which facilitated communication between ‘actors’. The
dimension of governance (leadership functions promot-
ing collaboration) was illustrated in participants’ eager-
ness to take the lead and secure relationships. Both
organisational dimensions, however, were hindered by
scarce official initiatives. For example, practices did not
divulge pharmacists’ integration which surprised partici-
pants who had limited time to adjust (including getting
used to ways of offsetting income reductions). Some par-
ticipants even ignored the presence of the other ‘actor’
making collaboration impossible. Additionally, lack of
information from professional bodies hindered partici-
pants’ understanding of the full benefits of the scheme
and generated suspicions about role clashes.
Internationally, there are mixed views on collabor-
ation between community pharmacies and general
practice-based pharmacists. Studies in Canada and
Australia have reported good relationships and mutual
support [44, 45]. Other Australian studies, in contrast,
have described community pharmacists’ reluctance to
collaborate or skepticism that pharmacists’ integration
might disrupt existing relationships between practices
and pharmacies [42, 43]. In England, one study re-
vealed significant tensions between community and
general practice-based pharmacists stemming from
professional hierarchy and competing, business-related
interests [46]. Our findings, however, are predomi-
nated by positive experiences and contradict experi-
mentally found or anecdotal frictions. A potential
reason for the difference between our findings and
those of the other English study is that their partici-
pants included general practice-based pharmacists not
part of the scheme. Our community pharmacy-based
participants had to deal with pharmacists in the
scheme who might have been more willing and ready
to collaborate with colleagues from community due
to their training that includes mandatory sessions on
how to build relationships with community pharma-
cies [52]. Indeed, a national survey of all pharmacists
integrated into general practice in the first phase of
the scheme highlighted increasing liaison with com-
munity pharmacies [9].
Implications
The study has several implications. There is a need to:
 Appropriately educate community pharmacy teams
(for example, via shadowing opportunities) about
general practice-based pharmacists’ scope of practice
and establish formal, regular meetings between com-
munity pharmacy and general practice staff.
 Update community pharmacy teams, in a timely and
detailed manner, about any future framing of
pharmacists’ presence in general practice (such as
expansion of presence or modifications in roles).
 Record the number of interactions with community
pharmacies amongst the impact measures for
general practice-based pharmacists.
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 Establish direct telephone lines or bleepers for
pharmacists covering multiple general practices.
Strengths and limitations
To our knowledge, this is the first study investigating
community pharmacy teams’ experiences of general
practice-based pharmacists. The qualitative design
allowed for an in-depth and thorough understanding
of participants’ views. The study captured the experi-
ences of the whole team in community pharmacies as
participants included pharmacists, pharmacy techni-
cians and pre-registration pharmacists. Findings ac-
count for various levels of working experience in
community pharmacy as well as different pharmacy
types. Although findings primarily apply to the UK,
individual elements will also inform international ef-
forts to integrate pharmacists into general practice
such as those in Australia, Canada, New Zealand,
Netherlands and the USA.
A limitation of the study is that participants were
solely recruited from one area. There might therefore
have been additional views of community pharmacy
teams in other areas, arising from different general
practice-based pharmacists’ employment models and
roles. The inclusion, however, of a large number of
participants ensured identification of a wide range of
experiences. The findings are, therefore, not generalis-
able but many insights might be transferable to other
similar settings. Although the presence of multiple in-
terviewers might translate to some differences in the
way interviews were conducted, the use of a common
interview schedule provided standardisation in the
depth and breadth of topics covered. Researchers
followed a reflexive approach throughout data analysis
and interpretation by ignoring any personal experi-
ences. Some unavoidable personal assumptions during
data categorisation might, however, still exist.
Conclusions
The current study revealed the potential impact of gen-
eral practice-based pharmacists on community pharma-
cies. No significant perceived opposition, from
community pharmacy teams, to the scheme was found.
Beside benefiting patients and GPs, which was the main
driver behind the scheme, pharmacists’ integration into
general practice has the potential to streamline the
workload of community pharmacy teams and enhance
their relationships with practices by enabling communi-
cation at a pharmacist-to-pharmacist level. This is an
important outcome in light of the recently announced
initiatives to better link general practice services with
the rest of community healthcare services in the UK.
Findings will therefore inform delivery of the NHS Long
Term Plan, so that any framing of pharmacists’ presence
in general practice includes the needs of community
pharmacies. Results will also assist any international pol-
icy that is setting out to integrate pharmacists into gen-
eral practice on how to better integrate care through
communication between general practice-based pharma-
cists and community pharmacies.
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